Silver Book Fact

Direct thrombin inhibitor reduced relative risk of venous thromboembolism

An investigational direct thrombin inhibitor reduced relative risk of venous thromboembolism after total hip replacement surgery by 65.7%—compared to a currently available treatment.

Fuji T, Fujita S, Kawai Y, Nakamura M, et al. Efficacy and Safety of Edoxaban Verus Enoxaparin for the Prevention of Venous Thrombembolism Following Total Hip Arthroplasty: STARS J-V Trial. Orlando, Florida: American Society of Hematology,2010 Annual Meeting; 2015. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534125/pdf/12959_2015_Article_57.pdf

Reference

Title
Efficacy and Safety of Edoxaban Verus Enoxaparin for the Prevention of Venous Thrombembolism Following Total Hip Arthroplasty: STARS J-V Trial
Publisher
American Society of Hematology,2010 Annual Meeting
Publication Date
2015
Authors
Fuji T, Fujita S, Kawai Y, Nakamura M, et al.
Volume & Issue
Volume 13, Issue 27
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • If all forms of cardiovascular disease were eliminated, life expectancy would rise by close to 7 years.  
  • Death rates from heart disease and stroke are falling in-part because of new drug treatments. According to the National Heart, Lung and Blood Institute, if death rates were the same…  
  • Glycoprotein inhibitors have been shown to reduce the risk of death, a second heart attack, or the need for revascularization by 48% to 52% in patients who have suffered a…  
  • Effect of optimal anticoagulation
    If 50% of atrial fibrillation patients who currently receive warfarin in routine medical care were optimally anticoagulated, 9,852 emboli would be prevented and $1.3 billion would be saved each year.  
  • Through advances in risk-factor assessment, detection, and preventive strategies, the average age of acute myocardial infarction and heart failure patients has shifted around 10 to 15 years forward. One-year…